Current status: 1056 hESC lines, 6767 hiPSC lines, and 168 clinical studies, and 2393 certificates
Monthly statistic from Jan 1, 2025
Posted on January 1, 2025
| total lines | 7823 |
| hESC lines | 1056 |
| hiPSC lines | 6767 |
| derivation countries | 50 |
| projects | 310 |
| providers | 956 |
| clinical studies | 168 |
| subclones | 3286 |
| certificates | 2393 |
| cell line certificates | 2246 |
| project certificates | 147 |